Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5280869
Max Phase: Preclinical
Molecular Formula: C52H68O6
Molecular Weight: 789.11
Associated Items:
ID: ALA5280869
Max Phase: Preclinical
Molecular Formula: C52H68O6
Molecular Weight: 789.11
Associated Items:
Canonical SMILES: COc1cc(OC/C=C(\C)C/C=C(\C)C/C=C(\C)C/C=C(\C)C/C=C(\C)C/C=C(\C)C/C=C(\C)C/C=C(\C)CC=C(C)C)c2c(=O)c3c(O)ccc(OC)c3oc2c1
Standard InChI: InChI=1S/C52H68O6/c1-35(2)13-14-36(3)15-16-37(4)17-18-38(5)19-20-39(6)21-22-40(7)23-24-41(8)25-26-42(9)27-28-43(10)31-32-57-47-33-44(55-11)34-48-50(47)51(54)49-45(53)29-30-46(56-12)52(49)58-48/h13,15,17,19,21,23,25,27,29-31,33-34,53H,14,16,18,20,22,24,26,28,32H2,1-12H3/b36-15+,37-17+,38-19+,39-21+,40-23+,41-25+,42-27+,43-31+
Standard InChI Key: DKRYDVGEOWMNIJ-DUFSGUAPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 789.11 | Molecular Weight (Monoisotopic): 788.5016 | AlogP: 14.71 | #Rotatable Bonds: 21 |
Polar Surface Area: 78.13 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 8.86 | CX Basic pKa: | CX LogP: 13.92 | CX LogD: 13.90 |
Aromatic Rings: 3 | Heavy Atoms: 58 | QED Weighted: 0.09 | Np Likeness Score: 0.90 |
1. Santos CMM, Freitas M, Fernandes E.. (2018) A comprehensive review on xanthone derivatives as α-glucosidase inhibitors., 157 [PMID:30282319] [10.1016/j.ejmech.2018.07.073] |
Source(1):